| __timestamp | ADMA Biologics, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 581800000 |
| Thursday, January 1, 2015 | 7015946 | 671900000 |
| Friday, January 1, 2016 | 7688238 | 876700000 |
| Sunday, January 1, 2017 | 6229587 | 857900000 |
| Monday, January 1, 2018 | 3926120 | 822200000 |
| Tuesday, January 1, 2019 | 2343848 | 778200000 |
| Wednesday, January 1, 2020 | 5907013 | 512600000 |
| Friday, January 1, 2021 | 3646060 | 681000000 |
| Saturday, January 1, 2022 | 3613764 | 662200000 |
| Sunday, January 1, 2023 | 3300000 | 910700000 |
Data in motion
In the ever-evolving landscape of biotechnology and pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Viatris Inc. and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Viatris Inc. consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately $911 million in 2023. This represents a robust 56% increase from its 2014 spending levels. In contrast, ADMA Biologics, Inc. has shown a more modest investment trajectory, with R&D spending decreasing by about 65% over the same period, from $9.5 million in 2014 to $3.3 million in 2023. This divergence highlights Viatris Inc.'s strategic focus on innovation, while ADMA Biologics, Inc. may be prioritizing other operational areas.
Zoetis Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Viatris Inc.
R&D Spending Showdown: BeiGene, Ltd. vs ADMA Biologics, Inc.
R&D Spending Showdown: Viatris Inc. vs Intra-Cellular Therapies, Inc.
Analyzing R&D Budgets: Viatris Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Viatris Inc. vs Amneal Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or ADMA Biologics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Blueprint Medicines Corporation vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
ADMA Biologics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
ADMA Biologics, Inc. vs MorphoSys AG: Strategic Focus on R&D Spending
ADMA Biologics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending